346 related articles for article (PubMed ID: 19801945)
41. Immune reconstitution inflammatory syndrome: incidence and implications for mortality.
Novak RM; Richardson JT; Buchacz K; Chmiel JS; Durham MD; Palella FJ; Wendrow A; Wood K; Young B; Brooks JT;
AIDS; 2012 Mar; 26(6):721-30. PubMed ID: 22233655
[TBL] [Abstract][Full Text] [Related]
42. Kaposi's sarcoma in pregnancy after initiation of highly active antiretroviral therapy: a manifestation of immune reconstitution syndrome.
Adeyemo A; Wood C; Govind A
Int J STD AIDS; 2012 Dec; 23(12):905-6. PubMed ID: 23258835
[TBL] [Abstract][Full Text] [Related]
43. Longitudinal sero-reactivity to human herpesvirus 8 (KSHV) in the Swiss HIV Cohort 4.7 years before KS.
Quinlivan EB; Wang RX; Stewart PW; Kolmoltri C; Regamey N; Erb P; Vernazza PL;
J Med Virol; 2001 Jun; 64(2):157-66. PubMed ID: 11360248
[TBL] [Abstract][Full Text] [Related]
44. Viral profiling identifies multiple subtypes of Kaposi's sarcoma.
Hosseinipour MC; Sweet KM; Xiong J; Namarika D; Mwafongo A; Nyirenda M; Chiwoko L; Kamwendo D; Hoffman I; Lee J; Phiri S; Vahrson W; Damania B; Dittmer DP
mBio; 2014 Sep; 5(5):e01633-14. PubMed ID: 25249280
[TBL] [Abstract][Full Text] [Related]
45. Immune reconstitution inflammatory syndrome associated with Kaposi sarcoma during potent antiretroviral therapy.
Connick E; Kane MA; White IE; Ryder J; Campbell TB
Clin Infect Dis; 2004 Dec; 39(12):1852-5. PubMed ID: 15578411
[TBL] [Abstract][Full Text] [Related]
46. Immune reconstitution inflammatory syndrome associated with toxoplasmic encephalitis in HIV-infected patients.
van Bilsen WPH; van den Berg CHSB; Rijnders BJA; Brinkman K; Mulder JW; Gelinck LBS; Hoepelman AIM; Wit FWNM; van de Beek D; Prins JM
AIDS; 2017 Jun; 31(10):1415-1424. PubMed ID: 28375874
[TBL] [Abstract][Full Text] [Related]
47. KSHV viral load and Interleukin-6 in HIV-associated pediatric Kaposi sarcoma-Exploring the role of lytic activation in driving the unique clinical features seen in endemic regions.
El-Mallawany NK; Mehta PS; Kamiyango W; Villiera J; Peckham-Gregory EC; Kampani C; Krysiak R; Sanders MK; Caro-Vegas C; Eason AB; Ahmed S; Schutze GE; Martin SC; Kazembe PN; Scheurer ME; Dittmer DP
Int J Cancer; 2019 Jan; 144(1):110-116. PubMed ID: 30204240
[TBL] [Abstract][Full Text] [Related]
48. Differences in Kaposi sarcoma-associated herpesvirus-specific and herpesvirus-non-specific immune responses in classic Kaposi sarcoma cases and matched controls in Sicily.
Amodio E; Goedert JJ; Barozzi P; Riva G; Firenze A; Bonura F; Viviano E; Romano N; Luppi M
Cancer Sci; 2011 Oct; 102(10):1769-73. PubMed ID: 21740480
[TBL] [Abstract][Full Text] [Related]
49. Predicting the evolution of Kaposi sarcoma, in the highly active antiretroviral therapy era.
El Amari EB; Toutous-Trellu L; Gayet-Ageron A; Baumann M; Cathomas G; Steffen I; Erb P; Mueller NJ; Furrer H; Cavassini M; Vernazza P; Hirsch HH; Bernasconi E; Hirschel B;
AIDS; 2008 May; 22(9):1019-28. PubMed ID: 18520345
[TBL] [Abstract][Full Text] [Related]
50. The clinical application of plasma Kaposi sarcoma herpesvirus viral load as a tumour biomarker: results from 704 patients.
Haq IU; Dalla Pria A; Papanastasopoulos P; Stegmann K; Bradshaw D; Nelson M; Bower M
HIV Med; 2016 Jan; 17(1):56-61. PubMed ID: 26111246
[TBL] [Abstract][Full Text] [Related]
51. Seroreactivity to Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) latent nuclear antigen in AIDS-associated Kaposi's sarcoma patients depends on CD4+ T-cell count.
de Souza VA; Pierrotti LC; Sumita LM; Freire WS; Segurado AA; Pannuti CS
J Med Virol; 2007 Oct; 79(10):1562-8. PubMed ID: 17705173
[TBL] [Abstract][Full Text] [Related]
52. Facing up to the ongoing challenge of Kaposi's sarcoma.
Robey RC; Bower M
Curr Opin Infect Dis; 2015 Feb; 28(1):31-40. PubMed ID: 25490104
[TBL] [Abstract][Full Text] [Related]
53. Immunological profiling of tuberculosis-associated immune reconstitution inflammatory syndrome and non-immune reconstitution inflammatory syndrome death in HIV-infected adults with pulmonary tuberculosis starting antiretroviral therapy: a prospective observational cohort study.
Ravimohan S; Tamuhla N; Steenhoff AP; Letlhogile R; Nfanyana K; Bellamy SL; MacGregor RR; Gross R; Weissman D; Bisson GP
Lancet Infect Dis; 2015 Apr; 15(4):429-38. PubMed ID: 25672566
[TBL] [Abstract][Full Text] [Related]
54. Therapeutic response of HIV-1 subtype C in African patients coinfected with either Mycobacterium tuberculosis or human herpesvirus-8.
Cassol E; Page T; Mosam A; Friedland G; Jack C; Lalloo U; Kopetka J; Patterson B; Esterhuizen T; Coovadia HM
J Infect Dis; 2005 Feb; 191(3):324-32. PubMed ID: 15633090
[TBL] [Abstract][Full Text] [Related]
55. Early development of immune reconstitution inflammatory syndrome related to Pneumocystis pneumonia after antiretroviral therapy.
Mok HP; Hart E; Venkatesan P
Int J STD AIDS; 2014 Apr; 25(5):373-7. PubMed ID: 24122663
[TBL] [Abstract][Full Text] [Related]
56. Kaposi Sarcoma Risk in HIV-Infected Children and Adolescents on Combination Antiretroviral Therapy From Sub-Saharan Africa, Europe, and Asia.
; Rohner E; Schmidlin K; Zwahlen M; Chakraborty R; Clifford G; Obel N; Grabar S; Verbon A; Noguera-Julian A; Collins IJ; Rojo P; Brockmeyer N; Campbell M; Chêne G; Prozesky H; Eley B; Stefan DC; Davidson A; Chimbetete C; Sawry S; Davies MA; Kariminia A; Vibol U; Sohn A; Egger M; Bohlius J
Clin Infect Dis; 2016 Nov; 63(9):1245-1253. PubMed ID: 27578823
[TBL] [Abstract][Full Text] [Related]
57. Antiretroviral therapy with protease inhibitors in human immunodeficiency virus type 1- and human herpesvirus 8-coinfected patients.
De Milito A; Catucci M; Venturi G; Romano L; Incandela L; Valensin PE; Zazzi M
J Med Virol; 1999 Feb; 57(2):140-4. PubMed ID: 9892398
[TBL] [Abstract][Full Text] [Related]
58. Immune Reconstitution Inflammatory Syndrome Associated Kaposi Sarcoma.
Poizot-Martin I; Brégigeon S; Palich R; Marcelin AG; Valantin MA; Solas C; Veyri M; Spano JP; Makinson A
Cancers (Basel); 2022 Feb; 14(4):. PubMed ID: 35205734
[TBL] [Abstract][Full Text] [Related]
59. Incidence and risk factors for the immune reconstitution inflammatory syndrome in HIV patients in South Africa: a prospective study.
Murdoch DM; Venter WD; Feldman C; Van Rie A
AIDS; 2008 Mar; 22(5):601-10. PubMed ID: 18317001
[TBL] [Abstract][Full Text] [Related]
60. AIDS-associated Kaposi sarcoma: outcomes after initiation of antiretroviral therapy at a university-affiliated hospital in urban Zimbabwe.
Nelson BC; Borok MZ; Mhlanga TO; Makadzange AT; Campbell TB
Int J Infect Dis; 2013 Oct; 17(10):e902-6. PubMed ID: 23809198
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
